Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Histrelin.
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Histrelin.
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Histrelin.
Advertisement
Amiodarone
Histrelin may increase the QTc-prolonging activities of Amiodarone.
Anagrelide
Histrelin may increase the QTc-prolonging activities of Anagrelide.
Arsenic Trioxide
Histrelin may increase the QTc-prolonging activities of Arsenic trioxide.
Advertisement
Artemether
Histrelin may increase the QTc-prolonging activities of Artemether.
Asenapine
Histrelin may increase the QTc-prolonging activities of Asenapine.
Azithromycin
Histrelin may increase the QTc-prolonging activities of Azithromycin.
Advertisement
Bedaquiline
Histrelin may increase the QTc-prolonging activities of Bedaquiline.
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Histrelin.
Canagliflozin Anhydrous
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Histrelin.
Capromab Pendetide
Histrelin may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Ceritinib
Histrelin may increase the QTc-prolonging activities of Ceritinib.
Chloroquine
Histrelin may increase the QTc-prolonging activities of Chloroquine.
Chlorpromazine
Histrelin may increase the QTc-prolonging activities of Chlorpromazine.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Histrelin.
CHOLINE C-11
The therapeutic efficacy of Choline C 11 can be decreased when used in combination with Histrelin.
Ciprofloxacin
Histrelin may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Histrelin may increase the QTc-prolonging activities of Cisapride.
Citalopram
Histrelin may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
Histrelin may increase the QTc-prolonging activities of Clarithromycin.
Clozapine
Histrelin may increase the QTc-prolonging activities of Clozapine.
Crizotinib
Histrelin may increase the QTc-prolonging activities of Crizotinib.
Disopyramide
Histrelin may increase the QTc-prolonging activities of Disopyramide.
Dofetilide
Histrelin may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Histrelin may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Histrelin may increase the QTc-prolonging activities of Domperidone.
Dronedarone
Histrelin may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Histrelin may increase the QTc-prolonging activities of Droperidol.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Histrelin.
Eliglustat
Histrelin may increase the QTc-prolonging activities of Eliglustat.
Empagliflozin
The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Histrelin.
Erythromycin
Histrelin may increase the QTc-prolonging activities of Erythromycin.
Escitalopram
Histrelin may increase the QTc-prolonging activities of Escitalopram.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Histrelin.
Flecainide
Histrelin may increase the QTc-prolonging activities of Flecainide.
Fluoxetine
Histrelin may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Histrelin may increase the QTc-prolonging activities of Flupentixol.
Gadobenate
Histrelin may increase the QTc-prolonging activities of Gadobenic acid.
Gemifloxacin
Histrelin may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Histrelin may increase the QTc-prolonging activities of Gemifloxacin.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Histrelin.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Histrelin.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Histrelin.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Histrelin.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Histrelin.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Histrelin.
Goserelin
Histrelin may increase the QTc-prolonging activities of Goserelin.
Granisetron
Histrelin may increase the QTc-prolonging activities of Granisetron.
Haloperidol
Histrelin may increase the QTc-prolonging activities of Haloperidol.
Ibutilide
Histrelin may increase the QTc-prolonging activities of Ibutilide.
Iloperidone
Histrelin may increase the QTc-prolonging activities of Iloperidone.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Histrelin.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Histrelin.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Histrelin.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Histrelin.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Histrelin.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Histrelin.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Histrelin.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Histrelin.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Histrelin.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Histrelin.
Lenvatinib
Histrelin may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Histrelin may increase the QTc-prolonging activities of Lenvatinib.
Leuprolide
Histrelin may increase the QTc-prolonging activities of Leuprolide.
Levofloxacin
Histrelin may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Histrelin may increase the QTc-prolonging activities of Levofloxacin.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Histrelin.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Histrelin.
Lopinavir
Histrelin may increase the QTc-prolonging activities of Lopinavir.
Lumefantrine
Histrelin may increase the QTc-prolonging activities of Lumefantrine.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Histrelin.
Methadone
Histrelin may increase the QTc-prolonging activities of Methadone.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Histrelin.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Histrelin.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Histrelin.
Moxifloxacin
Histrelin may increase the QTc-prolonging activities of Moxifloxacin.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Histrelin.
Nilotinib
Histrelin may increase the QTc-prolonging activities of Nilotinib.
Ofloxacin
Histrelin may increase the QTc-prolonging activities of Ofloxacin.
Ondansetron
Histrelin may increase the QTc-prolonging activities of Ondansetron.
Paliperidone
Histrelin may increase the QTc-prolonging activities of Paliperidone.
Panobinostat
Histrelin may increase the QTc-prolonging activities of Panobinostat.
Pazopanib
Histrelin may increase the QTc-prolonging activities of Pazopanib.
Pentamidine
Histrelin may increase the QTc-prolonging activities of Pentamidine.
Perflutren
Histrelin may increase the QTc-prolonging activities of Perflutren.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Histrelin.
Pimozide
Histrelin may increase the QTc-prolonging activities of Pimozide.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Histrelin.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Histrelin.
Primaquine
Histrelin may increase the QTc-prolonging activities of Primaquine.
Procainamide
Histrelin may increase the QTc-prolonging activities of Procainamide.
Promazine
Histrelin may increase the QTc-prolonging activities of Promazine.
Propafenone
Histrelin may increase the QTc-prolonging activities of Propafenone.
Quetiapine
Histrelin may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Histrelin may increase the QTc-prolonging activities of Quetiapine.
Quinidine
Histrelin may increase the QTc-prolonging activities of Quinidine.
Quinine
Histrelin may increase the QTc-prolonging activities of Quinine.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Histrelin.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Histrelin.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Histrelin.
Saquinavir
Histrelin may increase the QTc-prolonging activities of Saquinavir.
Saquinavir Mesylate
Histrelin may increase the QTc-prolonging activities of Saquinavir.
Saxagliptin
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Histrelin.
Saxagliptin Anhydrous
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Histrelin.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Histrelin.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Histrelin.
Sotalol
Histrelin may increase the QTc-prolonging activities of Sotalol.
Sulfisoxazole
Histrelin may increase the QTc-prolonging activities of Sulfisoxazole.
Telavancin
Histrelin may increase the QTc-prolonging activities of Telavancin.
Telithromycin
Histrelin may increase the QTc-prolonging activities of Telithromycin.
Tetrabenazine
Histrelin may increase the QTc-prolonging activities of Tetrabenazine.
Thioridazine
Histrelin may increase the QTc-prolonging activities of Thioridazine.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Histrelin.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Histrelin.
Toremifene
Histrelin may increase the QTc-prolonging activities of Toremifene.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Histrelin.
Vandetanib
Histrelin may increase the QTc-prolonging activities of Vandetanib.
Vemurafenib
Histrelin may increase the QTc-prolonging activities of Vemurafenib.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Histrelin.
Ziprasidone
Histrelin may increase the QTc-prolonging activities of Ziprasidone.
Zuclopenthixol
Histrelin may increase the QTc-prolonging activities of Zuclopenthixol.
